Nhi Van, Research Assistant in the laboratory of the Levy CIMAR’s Bree Aldridge, PhD, and a member of the Aldridge Lab’s “DiaMOND” team
Research Assistant in the laboratory of the Levy CIMAR’s Bree Aldridge, PhD, and a member of the Aldridge Lab’s “DiaMOND” team interested in learning to optimize drug combination therapies for tuberculosis and nontuberculous mycobacteria.
Applying Desirability of Outcome Ranking End Points
Clin Infect Dis; July 1, 2023
Establishing a baseline of antibiotic use in Massachusetts jails reveals heterogeneity in quantity of prescriptions and duration of therapy
Antimicrob Steward Health; June 21, 2023
Novel Synergies and Isolate Specificities in the Drug Interaction Landscape of Mycobacterium abscessus
Antimicrob. Agents Chemother.; June 6, 2023
Are fermented foods an overlooked reservoir of antimicrobial resistance?
Current Opinions in Food Science; June 5, 2023
Transcriptional Profiling for Infectious Disease Diagnostics and Discovery – Massachusetts General Hospital’s Roby Bhattacharyya, MD, PhD
Roby Bhattacharyya, MD, PhD, maintains a lab at the Broad where he and his team pursue basic and translational research on pathogenic microbes, with a particular focus on antimicrobial resistance and transcriptional responses to antibiotic exposure, and on characterizing their
Superbugs From Their Backyards and Beyond: Brockton High Schoolers Present “Tiny Earth” Findings to Levy CIMAR; Tufts Community
CIMAR hosted 33 students from Boston-area Brockton High School last week for a rare educational and networking opportunity. Students presented posters depicting original experiments and data on antimicrobial resistance to a wide audience of Tufts University and Tufts Medical Center